Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis. J of Skin. 2018;2(S1):S8. doi:10.25251/skin.2.supp.8